<DOC>
	<DOCNO>NCT00691912</DOCNO>
	<brief_summary>Today metastatic breast cancer regard cureless . The treatment palliative intent goal treatment include improvement quality life possible prolongation life . Treatment metastatic cancer usually involve hormone therapy and/or chemotherapy . Weekly application chemotherapeutical drug may lead less drug concentration healthy tissue therefore toxicity maý reduce .</brief_summary>
	<brief_title>Therapy Metastatic Breast Cancer With Paclitaxel Liposomal Doxorubicin</brief_title>
	<detailed_description>Breast cancer common malignancy female . In Germany 46,000 woman come breast cancer yearly . Present therapy cure metastatic disease , main focus improvement quality life prolongation life . It therefore necessary test new substance and/or new combination therapy concept . Among active cytotoxic agent use advanced breast cancer anthracyclines . Since conventional anthracyclines often use adjuvant neoadjuvant therapy cardiotoxicity restrict use therapy advanced disease . Liposomal encapsulate doxorubicin show well activity conventional doxorubicin combine reduced cardiotoxicity . Weekly apply cytotoxic agent show good toxicity profile hence cumulative dosis increase . It expect combination liposomal encapsulate doxorubicin paclitaxel give weekly show improve result therapy metastatic breast cancer .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>Women &gt; /= 18 year histologically proven metastatic breast cancer No prior chemotherapy advanced situation ECOG &lt; /= 2 Adequate bone marrow reserve leave ventricular ejection fraction ( LVEF ) &gt; /= 50 , measure within 4 week study treatment Existence write informed consent Previous high dose therapy stem cell support Prior adjuvant treatment cumulative anthracycline dose 600 mg/m² Epirubicin , 300 mg/m² Doxorubicin , 80 mg/m² Mitoxantrone Concomitant hormon chemotherapy radiation therapy Her2/neu overexpression pregnancy breast feeding</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>